FTB Advisors Inc. Purchases 14,265 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

FTB Advisors Inc. boosted its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 10.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 155,236 shares of the pharmacy operator’s stock after purchasing an additional 14,265 shares during the quarter. FTB Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $8,585,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Walgreens Boots Alliance by 11.0% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after buying an additional 1,169,600 shares during the last quarter. Northern Trust Corp boosted its position in shares of Walgreens Boots Alliance by 0.7% during the second quarter. Northern Trust Corp now owns 11,647,146 shares of the pharmacy operator’s stock valued at $636,750,000 after buying an additional 76,864 shares during the last quarter. Morgan Stanley boosted its position in shares of Walgreens Boots Alliance by 36.2% during the second quarter. Morgan Stanley now owns 4,913,030 shares of the pharmacy operator’s stock valued at $268,595,000 after buying an additional 1,304,949 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Walgreens Boots Alliance by 2.4% during the second quarter. Charles Schwab Investment Management Inc. now owns 3,794,775 shares of the pharmacy operator’s stock valued at $207,461,000 after buying an additional 90,568 shares during the last quarter. Finally, Parametric Portfolio Associates LLC boosted its position in shares of Walgreens Boots Alliance by 23.4% during the second quarter. Parametric Portfolio Associates LLC now owns 2,893,195 shares of the pharmacy operator’s stock valued at $158,171,000 after buying an additional 549,575 shares during the last quarter. Institutional investors and hedge funds own 59.76% of the company’s stock.

Shares of NASDAQ WBA traded down $0.47 during trading on Thursday, hitting $54.09. The company had a trading volume of 85,638 shares, compared to its average volume of 4,059,991. The stock has a 50 day simple moving average of $54.17 and a 200 day simple moving average of $53.31. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76. Walgreens Boots Alliance Inc has a 12 month low of $49.03 and a 12 month high of $86.31. The firm has a market capitalization of $49.96 billion, a P/E ratio of 8.98, a price-to-earnings-growth ratio of 1.42 and a beta of 0.89.

In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the transaction, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 15.73% of the stock is owned by company insiders.

Several research firms recently commented on WBA. Bank of America dropped their price objective on Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research report on Thursday, October 3rd. Morgan Stanley dropped their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research report on Friday, August 23rd. Royal Bank of Canada cut Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price on the stock. in a research report on Friday, September 27th. Cleveland Research reissued a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 9th. Finally, JPMorgan Chase & Co. cut Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $73.00 to $63.00 in a research report on Wednesday. Seven equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $61.65.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Google Finance Portfolio

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.